2013Unpublished venueRequires access

Efficacy evaluation of aztreonam in combination with cefepime for the treatment of urinary tract infectious

Luping Song

Open publisher page 0 citations

Abstract

Objective To explore the clinical efficacy of aztreonam in combination with cefepime for the treatment of urinary tract infections.Methods A randomized block grouping,123 cases of urinary tract infections were divided into observation group,aztreonam group and cefepime group,41 cases in each group.The observation group was treated with aztreonam (2.0g) and cefepime (2.0g),control group were given aztreonam and cefepime,respectively.The treatment time lasted 7 days.Results The total effective rate of observation group was 95.1%,compared with cefepime(85.4%)or aztreonam(82.9%) group,the difference was statistically significant(x2 =12.89、13.56,all P < 0.05).After the end of treatment,the observation group bacterial clearance rate (94.3%) was slightly higher than that of cefepime group or aztreonam group.Each group had only minor adverse reaction,which did't affect the continued medication.And the difference in the incidence was not statistically significant(P >0.05).Conclusion Cefepime joint aztreonam in the treatment of urinary tract infection can improve the therapeutic efficacy,and adverse events doesn't increase. Key words: Urinary tract infections ;  Aztreonam;  Cefepime

About this research paper

What this paper is about

Objective To explore the clinical efficacy of aztreonam in combination with cefepime for the treatment of urinary tract infections.Methods A randomized block grouping,123 cases of urinary tract infections were divided into observation group,aztreonam group and cefepime group,41 cases in each group.The observation group was treated with aztreonam (2.0g) and cefepime (2.0g),control group were given aztreonam and cefepime,respectively.The treatment time lasted 7 days.Results The total effective rate of observation group was 95.1%,compared with cefepime(85.4%)or aztreonam(82.9%) group,the difference was statistically significant(x2 =12.89、13.56,all P < 0.05).After the end of treatment,the observation group bacterial clearance rate (94.3%) was slightly higher than that of cefepime group or aztreonam group.Each group had only minor adverse reaction,which did't affect the continued medication.And the difference in the incidence was not statistically significant(P >0.05).Conclusion Cefepime joint aztreonam in the treatment of urinary tract infection can improve the therapeutic efficacy,and adverse events doesn't increase. Key words: Urinary tract infections ;  Aztreonam;  Cefepime

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical efficacy of aztreonam in combination with cefepime for the treatment of urinary tract infections.Methods A randomized block grouping,123 cases of urinary tract infections were divided into observation group,aztreonam group and cefepime group,41 cases in each group.The observation group was treated with aztreonam (2.0g) and cefepime (2.0g),control group were given aztreonam and cefepime,respectively.The treatment time lasted 7 days.Results The total effective rate of observation group was 95.1%,compared with cefepime(85.4%)or aztreonam(82.9%) group,the difference was statistically significant(x2 =12.89、13.56,all P < 0.05).After the end of treatment,the observation group bacterial clearance rate (94.3%) was slightly higher than that of cefepime group or aztreonam group.Each group had only minor adverse reaction,which did't affect the continued medication.And the difference in the incidence was not statistically significant(P >0.05).Conclusion Cefepime joint aztreonam in the treatment of urinary tract infection can improve the therapeutic efficacy,and adverse events doesn't increase. Key words: Urinary tract infections ;  Aztreonam;  Cefepime

Key concepts: Aztreonam, Cefepime, Medicine, Urinary system, Internal medicine, Adverse effect, Gastroenterology, Antibiotics

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy evaluation of aztreonam in combination with cefepime for the treatment of urinary tract infectious — Research Paper | ScholarLens